Table 4. Three Common FDA-Approved Candidate Drug Molecules Targeting EGFR and CTNNB1.

no.	gene	drug	approved	scores	reference (PubMed ID)
1	CTNNB1, EGFR	trametinib	FDA	1	26343583
					28783719
					26036643
					26582713
					27312529
2	CTNNB1, EGFR	temsirolimus	FDA	1	27016228
					24470557
3	CTNNB1, EGFR	imatinib	FDA	1	26861905
					28762371
					22323597